Cases 1 - 4 of 4
In Re: Ranbaxy Generic Drug Application Antitrust Litigation
as 1:2019md02878
In Re:
Ranbaxy Generic Drug Application Antitrust Litigation
Plaintiff:
Meijer, Inc., Meijer Distribution, Inc., Cesar Castillo, Inc. and others
Defendant:
Ranbaxy Laboratories Limited, Sun Pharmaceutical Industries Limited, Ranbaxy, Inc. and others
Consolidated Plaintiff:
United Food and Commercial Workers Health and Welfare Fund of Northern Pennsylvania and Louisiana Health Services and Indemnity Company d/b/a Blue Cross and Blue Shield of Louisiana
Respondent:
Prinston Pharmaceutical Inc.
Interested Party:
Novartis Pharmaceuticals Corporation and Astrazeneca Pharmaceuticals L.P.
Not Classified By Court:
Winifred Weitsen
Cause Of Action: 18 U.S.C. § 1962 Racketeering (RICO) Act
Williams v. Zhejiang Huahai Pharmaceutical Co., Ltd. et al
as 3:2019cv30014
Defendant:
Huahai U.S., Inc., Prinston Pharmaceutical, Inc., Solco Healthcare US, LLC and others
Plaintiff:
Charles Williams
Cause Of Action: 28 U.S.C. § 1332
Barboza et al v. Zhejiang Huahai Pharmaceutical Co., Ltd. et al
as 1:2019cv10074
Plaintiff:
Robert P. Barboza and Linda C. Barboza
Defendant:
Prinston Pharmaceutical, Inc., Solco Healthcare US, LLC and Zhejiang Huahai Pharmaceutical Co., Ltd.
Cause Of Action: 28 U.S.C. § 1332
MEIJER, INC. et al v. RANBAXY, INC. et al
as 1:2017cv11066
Petitioner:
Meijer, Inc. and Meijer Distribution, Inc.
Respondent:
Ranbaxy Inc., RANBAXY LABORATORIES, LTD., Ranbaxy U.S.A. Inc. and others
Plaintiff:
Prinston Pharmaceutical, Inc.
Cause Of Action: Motion to Quash
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
